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1. Introduction 
Enzymes, being asymmetric, have chiral active 
centers, are stereospecific and discriminate between 
different configurations of substrates, coenzymes and 
products. Stereoselective alkylation with asymmetric 
or chiral reagents can likewise result; this has been 
reported with ribonuclease [1,2], papain [3], yeast 
alcohol dehydrogenase [4] and yeast giyceraldehyde- 
phosphate dehydrogena~ [S]. With these enzymes 
inactivation showed different alkylation rates with 
the two enantiomers of haloacids and amides, but 
absolute discrimination between any of the 
enantiomers was not attained. 
The metal-directed affinity label (R,S)-2.bromo-3- 
(5.imidazolyl)propionic a id (BIP), has been shown 
to label cysteine-46 of liver alcohol dehydrogenase in 
a two step reaction [6,7]. A reversible complex is first 
formed as an intermediate by ligand binding to the 
active-site zinc atom through the imidazole ring. 
Labelling is no doubt highly dependent upon the 
conjuration of BIP, but thus far, this racemic label 
has not been resolved into its enantiomers. However, 
it has been possible to investigate the stereospecific 
role of configuration by synthesis of the pure 
enantiomers of the corresponding chlorocompounds; 
(R)- and (S)-2-chloro3(5Gmidazolyl)propionic acid 
(CIP), and the methylesters; (R)- and @)-methyl 
2-chloro-3-(5-imidazolyl)propionate (CIPME). 
In this work inactivation of liver alcohol 
dehydrogenase has been attempted with the two 
enantiomers of CIP and CIPME. The reaction was 
totally stereoselective or stereospecific. No reaction 
~Isevier~~orth-Holland Biomedical ?‘ress 
was observed with the (R)-enantiomers, while the 
(Sfenantiomers inactivated the enzyme in reactions 
where reversible complexes were formed as inter- 
mediates. Consequences result in the interpretation 
of the enzyme active-site chirality in solution. 
2. Materials and methods 
Source and assay of horse liver alcohol 
dehydrogena~ were as in [8]. The Iabelling reagents 
(R)- or ~~)-2.c~oro-3-(5-imidazolyl~ropioni~ acid 
(CIP) and (R)- or (5’).methyl2-chloro-3-(5.imidazolyl)- 
propionate (CIPME) were synthesized from D- and 
L-histidine [9]. Inactivations were performed as 
previously, except hat phosphate buffer pH 7.8, 
instead of pH 7.0 was used [lo]. Inactivation results 
were treated by logarithmic regression and plotted on 
semi-log paper. The apparent first-order ate constant 
(k’), was determined from the half-time of inactivation 
using k’ = (ln 2)/t%. This relation also gave ‘the 
m~mum ~activation half-time’ using the intercept 
on the l/k’-axis of the double reciprocal plot of k’ 
versus inactivator concentration. 
3. Results 
In fig.1, activity is plotted against time in a semi- 
log plot. It is evident hat (S)CIP inactivates the 
enzyme at 11; 0.20 n&I, while 25 mM (R)CIP cannot 
be distinguished from the control. Reaction with 
(5’)CIP is first order with respect o enzyme, as shown 
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Fig.1. Semi-log plots of inactivation versus time for liver alcohol dehydrogenase. Buffer was phosphate (pH 7.8) I = 0.1 M, 
temp. 23S’C and enzyme 0.6 m&ml. (o) Control; (0) 25 mM (R)CIP; (0) (SKIP (mM cont.). 
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Fig.2. Semi-log plots of inactivation versus time for liver alcohol dehydrogenase. Buffer was phosphate (pH 7.8) i= 0.1 M, temp. 
23.5% and enzyme 0.6 mg/ml. (o) Control; (0) 25 mM (R)CIPME; (0) (S)CIPME (mM corm.). 
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Fi@. Daubie-reciprocal plots of rate constivrts (k’) versus inactivator concentrations (4, (Q) @‘s)cIP (from f&l); (11) (SKIB?&4E 
C&m Fi.2). 
by linear ~a~tiYa~on curves, in particular that 
~orrespond~g toS mM. The double~~~~ro~~ plot
of rate constant versus @+JCI~ on~e~t~tion (fig3) 
shows saturation kinetics and indicates formation of 
a reversible nzyme-(S)CIP complex as an 
intermediate [6 J. The intercept on the 11 [@axis 
gives iKd 1.70 mM for the reversible nzyme-(S)CIP 
complex, The intercept on the l/k’-dis is 1320 mm, 
which gives a minimum inactivation half-time of 
915 n&L 
Rgure 2 shows intimation with (S~~P~~, while 
25 rn~(~~~M~ is ~~st~g~~able from the 
cX&rol. The linear ~a~~va~on curves how that the 
reaction is Rrst order with respect o ermyme. 
saturation kinetics are observed in the double 
reciprocal plot (fig.3). The minimum i~a~~va~~n 
half-time is 1700 min whiIe the Ka for the reversible 
enzyme-(S)CIPME complex is 1.20 mM, 
The (S~~~~tiorn~ of CIP- and ~~~E-~~acti~ated 
liver alcohol dehydrogen~~ while no reaction was 
observed with the (~~n~~~ers. Thus, there is 
absolute s~reo~le~ti~ty of the reaction, with the 
active site structure allowing a~ylat~on with only one 
of the e~~tiomers, This seems to be the first 
stereosele~tiv~ alkylation where ~s~~rna~o~ 
between enanliomers i shown to be absolute, 
When the liver enzyme was labelled with (R,S)G 
bromo3 @ 4midazolyl)propionic a id (BIP), it was 
documented that a reversible complex was formed 
as an intermediate, prior to irreversible alkylation 
163. The reversible complex was formed by ligand 
binding to the active&e zinc through the ~id~ole 
ring, The iteration kinetics een with variable on- 
centrations of (S)CB? or (S~~PME indicates asimilar 
mechanism for both these reagents. Scheme 1 
illustrates the echoic for the reaction between 
liver alcohol de~y~ogenase (E) and (R) or (S)CIP. 
E-(S)CIp denotes the irreversible complex. A 
corresponding scheme can be put up for (R)- and 
(S)CIPME :
E f (S)CrtP * E-(SJCIP + E-(S)CIF’ 
E + (R)t=IP =@ E-(R)ClP 
scheme 1 
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The (S)-enantiomers form a reversible complex 
with the enzyme prior to irreversible alkylation, while 
the (R)-enantiomers form a reversible complex which 
does not react further. The mechanism in scheme 1 
represents his absolute stereoselectivity, with 
discrimination i the irreversible alkylation. With the 
imidazole ring anchored at the zinc atom, the 
alkylating side chain orientates in the active-site cleft 
according to the interacting amino acid residues. Thus 
bound, specificity and stereoselectivity of alkylation 
depend upon side chain configuration. 
From the present investigations it cannot be 
excluded that formation of the reversible complex 
is also stereoselective. This results if the dissociation 
constants for the E-(S)CIP and the E-(R)CIP com- 
plexes are different. However, reversible complex 
formation alone cannot account for absolute 
stereoselectivity or stereospecificity. 
The reversible E-(QCIPME is somewhat more 
stable than the E-(S)CIP complex, as shown by Kd 
1.20 mM and 1.70 mM, respectively, which are of 
the same magnitude as that for the E-BIP complex, 
1 .I mM, at pH 7.0 [6]. However, alkylation proceeds 
faster with (S)CIP than (S)CIPME, as shown by 
minimum inactivation half-times of 9 15 min and 
1700 min, respectively. On the other hand, alkylation 
with BIP proceeds about 1 00-times faster, the 
minimum half-time being -9 min [6], a difference 
caused by the better leaving roup properties of 
bromide compared to chloride. 
Conclusions about metal active-site chirality or 
asymmetry in solution can be drawn from stereo- 
selective metal-directed affinity labelling of this and 
other enzymes. 
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